This Is What Whales Are Betting On DexCom
Portfolio Pulse from Benzinga Insights
A significant investor has taken a bearish stance on DexCom (NASDAQ:DXCM), with 81% of recent trades being bearish. The price target for DexCom over the last 3 months has been between $95.0 and $130.0. The current price of DXCM is $113.49, up 2.99%. Analysts from Barclays, Canaccord Genuity, Citigroup, Piper Sandler, and Raymond James have maintained their ratings on DexCom, with price targets ranging from $138 to $160.
August 09, 2023 | 2:02 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
A significant investor has taken a bearish stance on DexCom, which could potentially drive the stock price down in the short term. However, analysts have maintained their ratings, with price targets higher than the current price.
The bearish stance taken by a significant investor indicates a potential decrease in the stock price. However, the maintained ratings and higher price targets from analysts could counteract this effect.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100